Best Compounded GLP-1 for Beginners in 2026: Where to Start

Starting a GLP-1 medication is a significant decision, and the 2026 market has never offered more options — or more confusion. This guide is written for patients who are considering GLP-1 treatment for the first time and want to understand their options without the marketing spin.

Step 1: Compounded or Brand-Name?

This is the first fork in the road, and it comes down to two factors: cost and risk tolerance.

Step 2: Semaglutide or Tirzepatide?

Both are effective. The key differences:

• Semaglutide (Wegovy, Ozempic, or compounded): ~15% average weight loss. More providers, lower compounded pricing, more data (larger trial programs).
• Tirzepatide (Zepbound, Mounjaro, or compounded): ~22.5% average weight loss. More effective but more expensive compounded, and the regulatory pathway for compounded tirz is more restricted.

For most beginners, semaglutide is the practical starting point. It's cheaper, more widely available, and has the longest safety track record. If you plateau or want more aggressive results, tirzepatide is the natural next step.

Step 3: What to Expect in Month 1

Regardless of which medication or provider you choose, here's what the first month typically looks like:

Week 1: You'll start at the lowest dose. Most patients notice reduced appetite within the first few days. Some experience mild nausea — this is the most common side effect and usually improves over 2–4 weeks.

Weeks 2–3: Appetite suppression becomes more consistent. Most patients describe it as "food noise" quieting down — you still enjoy food, but the constant background cravings diminish. Weight loss typically begins here, usually 2–5 lbs in the first month.

Week 4: First dose increase (titration). Your provider will move you to the next dose level. Nausea may briefly return at the new dose, then settle again.

Step 4: Choosing a Provider

For first-time patients, prioritize these factors in order:

1. Medical oversight: Choose a provider that includes physician consultation, not just a questionnaire-to-prescription pipeline. You want someone monitoring your response and adjusting your dose.

2. Clear pricing: Know your total monthly cost at every dose tier, including consultations, membership fees, and shipping. No surprises.

3. Pharmacy quality: Verify LegitScript certification, PCAB accreditation, or state licensure. Ask if a Certificate of Analysis is available.

4. Cancellation flexibility: Avoid long-term commitments for your first provider. You want the ability to switch if the platform doesn't work for you.

Provider Recommendations for Beginners

Best all-around starter (compounded): Embody at $149 first month. Physician-supervised, structured onboarding, injectable semaglutide. The $149 entry point matches brand-name pricing, and you get hands-on medical oversight.

Best budget entry (compounded): GobyMeds at $99/mo. Lowest legitimate price on the market. LegitScript certified, 503A+503B pharmacies. No membership fees. Code x7X72r saves an additional $25.

Best for needle-averse (compounded): SkinnyRx at $149/mo. Offers sublingual and tablet formats alongside injectable — so you can choose your preferred delivery method.

Best brand-name entry: Wegovy pill or Foundayo at $149/mo. FDA-approved, no compounding uncertainty. Foundayo has the edge with no food restrictions; Wegovy pill requires a 30-minute morning fast.

Best if on Medicare: Wait for the GLP-1 Bridge (July 1, 2026) — $50/mo for Wegovy, Zepbound, or Foundayo.

What About MEDVi?

MEDVi offers compounded semaglutide from $179/month with no contract. Note that MEDVi received an FDA warning letter in February 2026 regarding marketing practices. The company continues to operate, but patients should be aware of this regulatory history when making their decision.